🩺 Community Question:
Are drug prices too high, or are they fair given the cost of R&D?
A. Drug prices are reasonable, high costs are necessary to support R&D and innovation
B. Drug prices are too high, they don't truly reflect R&D costs so people end up paying far more than
🩺 Community Question:
Which shift would best move today’s “sickcare” model toward real healthcare?
Viewpoint A:
Keep prioritizing hospitals, believing the system improves most by delivering stronger care at the moment people actually need it.
Viewpoint B:
Prioritize
🩺 Community Question:
What should health apps focus on to actually help people stay healthy over time?
Viewpoint A:
Help people book doctors, manage visits, and deal with sick care when problems happen.
Viewpoint B:
Build on an intelligence layer that supports daily health and
🩺 Community Question:
In areas facing extreme doctor shortages, can AI doctor truly be considered a real solution for improving healthcare access?
Viewpoint A:
Yes. AI doctors can deliver 24/7 diagnostics, symptom triage, and medical guidance at scale, often matching or
🩺 Community Question:
Will AI in healthcare improve care and safety or entrench bias and threaten privacy?
Viewpoint A:
AI can improve detection, efficiency, and access when validated and regulated
Viewpoint B:
AI carries risks such as bias, poor generalization, and privacy
🩺 Community Question:
If healthcare really is broken, what’s the best way to fix it?
Viewpoint A:
Break the current system and take on the big players, including drug companies, hospitals, and insurers, to change the rules and rebuild healthcare from the ground up.
Viewpoint
🩺 Community question:
Where will the next major breakthrough in healthcare come from?
Viewpoint A:
From established systems like the US and UK where world-class institutions, funding, and decades of research infrastructure continue to drive innovation.
Viewpoint B:
From
🩺Community Question:
Should healthcare prioritize personalized care for individuals, or one-size-fits-all care for everyone?
Viewpoint A: One-size-fits-all as the default
Standardized care is more practical, affordable, and equitable for large populations and resource-limited
🩺 Community Question
Is personalized care realistic for low- and middle-income countries (LMICs), or is it still a model built mainly for high-income countries (HICs)?
Viewpoint A: Gradually achievable in LMICs
Personalized care can scale over time. Costs of genetic and digital
💊 Community Question:
Can AI help discover and develop new medicines much faster and cheaper than traditional methods?
Viewpoint A:
Yes. AI can rapidly test millions of drug ideas, cut early research time and costs dramatically, and in some cases bring medicines to patients